Zhibin Hu

35.8k citations
499 papers · 17.4k indexed · 5 hit papers · h-index 59
Topics
RNA modifications and cancer (91 papers)Cancer-related molecular mechanisms research (89 papers)MicroRNA in disease regulation (55 papers)

In The Last Decade

Zhibin Hu

488 papers receiving 17.2k citations

Hit Papers

Clinical characteristics of...200820262014202020202010200820232020250500750

Peers

Zhibin Hu
Comparison fields: 5 of 186
  • Molecular Biology 9.9k
  • Cancer Research 7.1k
  • Oncology 2.5k
  • Epidemiology 1.7k
  • Genetics 1.6k
Replace Hongbing Shen with:
Hongbing Shen China
Guangfu Jin China
Lucio Miele United States
Feng Chen China
Melissa L. Bondy United States
Sara Gandini Italy
Wei Zhang China
Hongxia Ma China
Li Liu China
Christopher I. Amos United States
Zhibin Hu relative to Hongbing Shen China Hongbing Shen's profile →
Citations per field
00.5×1.5×1.8×
Hongbing Shen · 1×
Citations per year

Countries citing papers authored by Zhibin Hu

Since Specialization
Citations

This map shows the geographic impact of Zhibin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhibin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhibin Hu more than expected).

Fields of papers citing papers by Zhibin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhibin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhibin Hu. The network helps show where Zhibin Hu may publish in the future.

Co-authorship network of co-authors of Zhibin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhibin Hu. A scholar is included among the top collaborators of Zhibin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhibin Hu. Zhibin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 6
5 6
6 11
7 6
8 38
9 51
10 65
11 13
12 11
13 9
14 20
15 44
16 26
17 196
18 373
19 114
20 138

About Zhibin Hu

Zhibin Hu is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 499 papers that have together received 17.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (91 papers), Cancer-related molecular mechanisms research (89 papers) and MicroRNA in disease regulation (55 papers). The work is most often cited by research in Cancer Research (7.1k citations), Molecular Biology (9.9k citations) and Reproductive Medicine (880 citations). Zhibin Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hongbing Shen, Guangfu Jin, Hongxia Ma, Juncheng Dai, Qingyi Wei, Chen‐Yu Zhang, Tian Tian, Ke Zen, Yijiang Chen and Xinru Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026